On October 15, 2023, on the occasion of the 118th anniversary of China Agricultural University, the signing ceremony for the transformation of major scientific and technological achievements of China Agricultural University kicked off.

Academician Zhong Nanshan said at the Biomedicine and Health sub-forum of the 2023 Greater Bay Area Science Forum that the forecast based on the seirs model shows that the peak of the second wave of the SARS-CoV-2 epidemic in 2023 will occur at the end of June, about 65 million per week.

On the afternoon of December 21, Xiamen Wiz Biotech Co., Ltd. and Xiamen Zhuqiang Large Pharmacy Co., Ltd. had an in-depth discussion on how to meet citizens' demand for novel coronavirus antigen test kits, reached and established a strategic partnership, to assist Xiamen in epidemic prevention and control.

On December 21, Xiamen Wiz Biotech Co., Ltd and Xiamen Luyan Pharmacy Co., Ltd signed a strategic cooperation on COVID-19 antigen test kit. Su Jinkun (Mr.), General manager of Xiamen Luyan Pharmacy, Lin Lin (Ms.), Deputy general manager of Retail Division of Luyan Group, and Wang Xiaozhen (Ms.), general manager of Wiz Biotech, Sales Director Peng Que'en (Mr.) attended the ceremony.

According to the latest HSC Common List published on October 17, 2022, the SARS-CoV-2 Antigen Rapid Test produced by Wizbiotech has been listed in HSC Common List Class A.

In the workshop of Xiamen Wiz Biotech Co., Ltd, workers dressed in neat overalls sit in front of the operating table and methodically pack test reagents for COVID-19 antigen.

As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.

iamen Wiz Biotech Co., Ltd is located in Xiamen Biopharmaceutical Port. The company takes rapid diagnosis as its entry point and focuses on gastrointestinal and digestive fields. From research and development, registration and approval, to market access, sales network......

Our company's "Novel Coronavirus Antibody Screening and Shunt Prevention and Control rapid detection system" has been approved by Xiamen Science and Technology Bureau.